Media stories about Colgate-Palmolive (NYSE:CL) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Colgate-Palmolive earned a news sentiment score of 0.23 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.944311083243 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the news stories that may have impacted Accern Sentiment’s analysis:
- Predicting What Colgate-Palmolive’s Price Action Will Be Over The Next 3 Days (finance.yahoo.com)
- Colgate-Palmolive Company (CL) estimated to achieve -4.70% EPS growth for this year – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Colgate-Palmolive (CL) Expected to Post Earnings of $0.74 Per Share (americanbankingnews.com)
- Hot Mover of the Day – Colgate-Palmolive Company (NYSE: CL) – Alpha Beta Stock (alphabetastock.com)
- Is Colgate-Palmolive Company (NYSE:CL) Expensive For A Reason? A Look At The Intrinsic Value (finance.yahoo.com)
Several equities research analysts recently issued reports on CL shares. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Societe Generale lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target on the stock. in a report on Wednesday, November 29th. They noted that the move was a valuation call. Deutsche Bank started coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target on the stock. Macquarie raised shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a report on Tuesday, December 19th. Finally, Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $77.91.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.75. The firm had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.75 EPS. sell-side analysts expect that Colgate-Palmolive will post 3.18 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be given a $0.42 dividend. The ex-dividend date is Thursday, April 19th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.37%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. Colgate-Palmolive’s payout ratio is 61.78%.
In related news, CTO Patricia Verduin sold 1,572 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $70.17, for a total transaction of $110,307.24. Following the transaction, the chief technology officer now owns 50,675 shares in the company, valued at approximately $3,555,864.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jennifer Daniels sold 7,375 shares of the business’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total transaction of $539,702.50. Following the transaction, the insider now owns 38,691 shares in the company, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. Insiders sold a total of 463,082 shares of company stock worth $32,983,130 in the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.